Trademark: 78128319
Word
TESCALA
Status
Dead
Status Code
606
Status Date
Sunday, January 29, 2006
Serial Number
78128319
Mark Type
1000
Filing Date
Monday, May 13, 2002
Published for Opposition
Tuesday, November 5, 2002
Abandoned Date
Sunday, January 29, 2006

Trademark Owner History
Pfizer Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, preparations to lower cholesterol, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations

Trademark Events
Apr 4, 2006
Abandonment Notice Mailed - No Use Statement Filed
Apr 4, 2006
Abandonment - No Use Statement Filed
Jun 16, 2005
Extension 5 Granted
Jun 16, 2005
Extension 5 Filed
Jun 16, 2005
Teas Extension Received
Jan 21, 2005
Extension 4 Granted
Jan 5, 2005
Extension 4 Filed
Jan 5, 2005
Teas Extension Received
Jan 5, 2005
Attorney Revoked And/Or Appointed
Jan 5, 2005
Teas Revoke/Appoint Attorney Received
Apr 22, 2004
Extension 3 Granted
Apr 7, 2004
Extension 3 Filed
Apr 15, 2004
Case File In Ticrs
Apr 7, 2004
Paper Received
Nov 21, 2003
Extension 2 Granted
Nov 21, 2003
Extension 2 Filed
Nov 26, 2003
Paper Received
Jun 4, 2003
Extension 1 Granted
May 1, 2003
Extension 1 Filed
May 1, 2003
Teas Extension Received
Jan 28, 2003
Noa Mailed - Sou Required From Applicant
Nov 5, 2002
Published For Opposition
Oct 16, 2002
Notice Of Publication
Sep 16, 2002
Approved For Pub - Principal Register
Sep 16, 2002
Examiner's Amendment Mailed
Aug 29, 2002
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24